2020 BioHealth Capital Region Forum

Top 3 by 2023

***PLEASE NOTE: the date of this forum has shifted to April 14-15th from April 15th-16th. We hope you still will be able to join us! ***

About

This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, VirginiaBio, Children’s National Health System, Johns Hopkins University, Maryland Department of Commerce, Quality Biologics, George Mason University, University System of Maryland and AstraZeneca. Maryland, Virginia, and Washington, DC set the bar high for biotech innovation. So please join us for our Annual BioHealth Capital Region Forum that will highlight the accomplishments of today and chart our successes of tomorrow.

2020 Agenda

AGENDA COMING SOON!

Agenda Coming Soon!

SPONSOR BY:

Finalists will have a chance to win the grand prize by presenting in front of a panel of prominent industry funding experts and executives.

DISTINGUISHED JUDGES

Moderator – Rich Bendis, President & CEO, BioHealth Innovation, Inc.
2020 Judges:

  • Judges to be named soon!

2020 FINALISTS

2020 Finalists will be posted this spring!

CRITERIA
Product
Leadership Team
Marketing/Strategy
Technical Feasibility
Financial/Projection
PRIZES
$10,000
Grand Prize provided by WSGR
Visibility in front of hundreds of attendees and prominent industry and venture capital judges

Previous Crab Trap Winners

2019 – Floreo Inc.
Floreo is leveraging the power of Virtual Reality to develop a supplementary method of teaching social and communication skills for individuals with Autism Spectrum Disorder (ASD). Our library of lessons is fun and engaging for the learner, while also providing a supervising adult the opportunity to monitor and track the learner’s progress. Floreo is currently being used by schools, therapy practices, and parents. Floreo’s lessons are science-based; we are currently running several research studies including a study in collaboration with the Center for Autism Research at Children’s Hospital of Philadelphia and National Institutes of Health.
2018 – Galen Robotics
Galen Robotics, is developing, in partnership with JHU, a surgical robot to make minimally invasive surgeries faster, safer and more precise. The company plans a 510k submission next year, is raising Series A financing, and will be relocating the HQ team in CA to join their engineering experts in Baltimore.
2017 – LifeSprout
LifeSprout, developer of revolutionary synthetic soft tissues for aesthetic and reconstructive medicine. Leveraging recent breakthroughs in materials science, they have created a platform that looks and behaves like the body’s own tissues.
2016 –  Sonavex
Sonavex, a commercial stage Johns Hopkins spin-out focused on Empowered Patient Care.  The company’s first technology is a dual-component system comprising an FDA-cleared bioabsorbable implant (EchoMark) and an FDA-cleared custom automated ultrasound (EchoSure) to detect post-operative vascular complications prior to catastrophic surgical failures that represent a $3B annual market and cost hospitals up to $577,000 per instance.